The AI infrastructure maker's earnings beat and capex raise signal surging data-center spending ahead of Big Tech results.

The card giant is betting AI will let it run leaner, but the restructuring charge hits right as investors digest Q3 results.

Late-stage win sets up regulatory talks and could reshape how cancer is treated - and how biotech investors value mRNA platforms.

Fiscal Q3 results crush estimates, prove AI memory is rewriting Micron's margins, and change the momentum math for the whole chip stack.